Detalles de la búsqueda
1.
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.
N Engl J Med
; 388(22): 2058-2070, 2023 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37256976
2.
An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancer.
Breast Cancer Res Treat
; 195(3): 275-287, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35915198
3.
Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials.
Breast Cancer Res Treat
; 186(2): 417-428, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33392835
4.
Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy: A Prespecified Analysis of the monarchE Randomized Clinical Trial.
JAMA Oncol
; 8(8): 1190-1194, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35653145
5.
Noncardiac vascular toxicities of vascular endothelial growth factor inhibitors in advanced cancer: a review.
Oncologist
; 16(4): 432-44, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21441297
6.
Evaluation of nuclear factor κB and chemokine receptor CXCR4 co-expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610.
BJU Int
; 108(2 Pt 2): E51-8, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21156016
7.
MONARCH 2: Subgroup Analysis of Patients Receiving Abemaciclib Plus Fulvestrant as First-Line and Second-Line Therapy for HR+, HER2--Advanced Breast Cancer.
Clin Cancer Res
; 27(21): 5801-5809, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34376533
8.
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A Randomized Clinical Trial.
JAMA Oncol
; 6(1): 116-124, 2020 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31563959
9.
An open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancer.
Cancer Med
; 7(5): 1660-1669, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29573207
10.
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy.
J Clin Oncol
; 35(25): 2875-2884, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28580882
11.
Multinational study exploring patients' perceptions of side-effects induced by chemo-radiotherapy.
Radiother Oncol
; 117(2): 333-7, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26372344
12.
Symptomatic Histologically Proven Necrosis of Brain following Stereotactic Radiation and Ipilimumab in Six Lesions in Four Melanoma Patients.
Case Rep Oncol Med
; 2014: 417913, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25105043
13.
Desmoplastic small round cell tumour: an unusual presentation of an unusual tumour.
Med J Aust
; 192(3): 172-3, 2010 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20121690
Resultados
1 -
13
de 13
1
Próxima >
>>